TRIALSITEIQ PUBLIC FEASIBILITY SCORECARD · GRADE C

NCT06310291: VTP-1000 in Adults With Celiac Disease

Sponsor: Barinthus Biotherapeutics · Phase: PHASE1 · Area: CARDIOLOGY_METABOLIC · Target Enrollment: 45 pts

Competing Trials Overlap

11 Active Trials

Excess Burn Exposure

$1,354,560

Rescue Site Savings

+$903,040

Unlock Full NCT06310291 Backup Super-Site Packet ($49 One-Time Pass)

Download the complete list of top-decile low-cannibalization clinical sites, verified Principal Investigator (PI) direct emails/phones, and protocol optimization benchmarks.

Download $49 NCT06310291 Rescue Dossier →